|
chr5_-_149792370
|
5.428
|
NM_001025158
NM_001025159
NM_004355
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
chr19_-_7764283
|
4.665
|
NM_001207019
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
chr14_-_107179043
|
4.533
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
chr5_-_149792276
|
4.247
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
chr6_+_6588933
|
3.835
|
NM_004271
|
LY86
|
lymphocyte antigen 86
|
|
chr22_+_23213671
|
3.598
|
|
IGLV4-3
|
immunoglobulin lambda variable 4-3
|
|
chr22_+_22723972
|
2.986
|
|
|
|
|
chr11_+_121461070
|
2.808
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
chr19_+_45452427
|
2.806
|
|
APOC2
|
apolipoprotein C-II
|
|
chr11_+_22689653
|
2.673
|
NM_177553
|
GAS2
|
growth arrest-specific 2
|
|
chr11_+_22696318
|
2.597
|
NM_005256
|
GAS2
|
growth arrest-specific 2
|
|
chr4_+_74281884
|
2.556
|
|
ALB
|
albumin
|
|
chrX_+_128913881
|
2.462
|
NM_018990
|
SASH3
|
SAM and SH3 domain containing 3
|
|
chr1_-_160681552
|
2.399
|
NM_001778
|
CD48
|
CD48 molecule
|
|
chr21_-_46340821
|
2.375
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
chr7_+_99816870
|
2.354
|
NM_024070
|
PVRIG
|
poliovirus receptor related immunoglobulin domain containing
|
|
chr7_+_26403944
|
2.333
|
NM_001199838
|
SNX10
|
sorting nexin 10
|
|
chr14_+_75988838
|
2.307
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
chr4_-_40631846
|
2.289
|
NM_001098634
|
RBM47
|
RNA binding motif protein 47
|
|
chrX_+_128913897
|
2.228
|
|
SASH3
|
SAM and SH3 domain containing 3
|
|
chr14_+_75988765
|
2.218
|
NM_006399
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
chr2_+_228678556
|
2.178
|
NM_001130046
NM_004591
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
chr14_-_107013474
|
2.152
|
|
IGHA1
IGHG1
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
chr12_-_53600999
|
1.940
|
NM_000889
|
ITGB7
|
integrin, beta 7
|
|
chr19_+_40194945
|
1.929
|
NM_020129
NM_203471
|
LGALS14
|
lectin, galactoside-binding, soluble, 14
|
|
chr12_-_53601051
|
1.874
|
|
ITGB7
|
integrin, beta 7
|
|
chr14_-_106746056
|
1.871
|
|
|
|
|
chr1_+_26644458
|
1.819
|
|
CD52
|
CD52 molecule
|
|
chr22_+_25003610
|
1.817
|
NM_001032365
|
GGT1
|
gamma-glutamyltransferase 1
|
|
chr14_-_106208537
|
1.803
|
|
|
|
|
chr13_+_31309690
|
1.782
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
chr14_-_106471439
|
1.751
|
|
IGHA1
IGHG1
IGHM
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant mu
|
|
chr10_-_90712510
|
1.711
|
NM_001613
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
chr14_-_106774311
|
1.701
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
chr14_-_65409445
|
1.664
|
NM_002083
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal)
|
|
chr13_-_46742678
|
1.650
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
chr14_-_107078578
|
1.626
|
|
|
|
|
chr22_+_24999113
|
1.590
|
NM_001032364
NM_005265
|
GGT1
|
gamma-glutamyltransferase 1
|
|
chr6_+_87969619
|
1.571
|
|
ZNF292
|
zinc finger protein 292
|
|
chr1_+_26644380
|
1.515
|
NM_001803
|
CD52
|
CD52 molecule
|
|
chr19_-_9695166
|
1.480
|
NM_001008727
|
ZNF121
|
zinc finger protein 121
|
|
chr17_+_53342356
|
1.479
|
|
HLF
|
hepatic leukemia factor
|
|
chr14_-_106518424
|
1.473
|
|
IGH@
IGHA1
IGHG1
IGHG2
IGHM
|
immunoglobulin heavy locus
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant gamma 2 (G2m marker)
immunoglobulin heavy constant mu
|
|
chrX_-_105282714
|
1.441
|
NM_000354
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
|
chr11_-_2158510
|
1.414
|
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
|
chr3_+_112051914
|
1.351
|
NM_001004196
NM_005944
|
CD200
|
CD200 molecule
|
|
chr13_+_31309644
|
1.300
|
NM_001629
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
chr21_+_27012045
|
1.274
|
|
JAM2
|
junctional adhesion molecule 2
|
|
chr1_+_156123321
|
1.269
|
NM_001193300
NM_022367
NM_001193302
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
|
|
chr17_-_39092714
|
1.230
|
|
KRT23
|
keratin 23 (histone deacetylase inducible)
|
|
chr5_-_150467220
|
1.221
|
NM_001252390
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
chrX_-_33357725
|
1.160
|
NM_000109
|
DMD
|
dystrophin
|
|
chr3_+_112052020
|
1.158
|
|
CD200
|
CD200 molecule
|
|
chr14_-_106405633
|
1.142
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
chr21_-_46340776
|
1.118
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
chr1_+_207262211
|
1.113
|
NM_001017365
NM_001017366
|
C4BPB
|
complement component 4 binding protein, beta
|
|
chr1_+_161632904
|
1.110
|
NM_001002273
NM_001002274
NM_001002275
NM_001190828
NM_004001
|
FCGR2B
FCGR2C
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
chr5_-_150466696
|
1.096
|
NM_001252391
NM_001252392
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
chrX_-_32173585
|
1.092
|
NM_004013
NM_004020
NM_004021
NM_004022
NM_004023
|
DMD
|
dystrophin
|
|
chr1_+_111413820
|
1.069
|
NM_001040033
|
CD53
|
CD53 molecule
|
|
chr17_+_75446612
|
1.069
|
NM_001113496
|
SEPT9
|
septin 9
|
|
chr3_+_98250742
|
1.057
|
NM_005290
|
GPR15
|
G protein-coupled receptor 15
|
|
chr12_+_54891539
|
1.021
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
chr6_+_33043702
|
1.002
|
NM_002121
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
chr3_+_133494275
|
1.002
|
|
TF
|
transferrin
|
|
chr6_-_112194430
|
0.961
|
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
|
chr16_-_28608367
|
0.949
|
NM_001054
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
|
chr17_+_53342320
|
0.910
|
NM_002126
|
HLF
|
hepatic leukemia factor
|
|
chr1_+_6105980
|
0.899
|
NM_001199862
|
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2
|
|
chr8_-_103137134
|
0.897
|
NM_001040630
|
NCALD
|
neurocalcin delta
|
|
chrX_+_1455508
|
0.876
|
NM_002183
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
chr2_+_75059781
|
0.870
|
NM_000189
|
HK2
|
hexokinase 2
|
|
chr17_+_72462766
|
0.856
|
|
CD300A
|
CD300a molecule
|
|
chr19_-_10450262
|
0.853
|
NM_002162
|
ICAM3
|
intercellular adhesion molecule 3
|
|
chrY_+_1405508
|
0.845
|
NM_002183
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
chr2_-_175462428
|
0.840
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
chr22_-_37545944
|
0.831
|
NM_000878
|
IL2RB
|
interleukin 2 receptor, beta
|
|
chr6_+_167525294
|
0.824
|
NM_004367
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
chr19_-_41196419
|
0.819
|
NM_004756
|
NUMBL
|
numb homolog (Drosophila)-like
|
|
chr14_-_106092256
|
0.818
|
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker)
|
|
chr17_+_16319087
|
0.814
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
chr8_+_28174648
|
0.805
|
NM_006228
|
PNOC
|
prepronociceptin
|
|
chr14_-_106111114
|
0.784
|
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker)
|
|
chr12_+_54891522
|
0.776
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
chr8_-_28347733
|
0.775
|
NM_172366
|
FBXO16
ZNF395
|
F-box protein 16
zinc finger protein 395
|
|
chr7_-_20256942
|
0.754
|
NM_182762
|
MACC1
|
metastasis associated in colon cancer 1
|
|
chr14_-_106237675
|
0.743
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
chr1_+_26856259
|
0.734
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
chr21_+_34602273
|
0.720
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
chr21_-_46340874
|
0.716
|
NM_000211
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
chr6_-_112194648
|
0.691
|
NM_002037
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
|
chr21_+_34602304
|
0.687
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
chr3_-_13384746
|
0.685
|
|
NUP210
|
nucleoporin 210kDa
|
|
chr17_+_72462521
|
0.685
|
NM_007261
|
CD300A
|
CD300a molecule
|
|
chr6_+_30227335
|
0.672
|
|
HLA-L
|
major histocompatibility complex, class I, L, pseudogene
|
|
chr14_-_24777153
|
0.665
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
chr11_-_70672644
|
0.663
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
|
chr14_-_107170400
|
0.663
|
|
IGHV4-31
IGHV1-69
IGHA1
IGHG1
IGHG3
IGHM
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy variable 1-69
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant gamma 3 (G3m marker)
immunoglobulin heavy constant mu
|
|
chr14_-_107066061
|
0.659
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
chr9_-_72873739
|
0.655
|
|
LOC100507299
|
uncharacterized LOC100507299
|
|
chr1_+_87380437
|
0.651
|
|
HS2ST1
|
heparan sulfate 2-O-sulfotransferase 1
|
|
chr22_+_22712091
|
0.634
|
|
IGLV1-44
IGL@
|
immunoglobulin lambda variable 1-44
immunoglobulin lambda locus
|
|
chr12_+_113416267
|
0.633
|
NM_001032731
NM_002535
NM_016817
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa
|
|
chr1_-_155904201
|
0.632
|
|
KIAA0907
|
KIAA0907
|
|
chr13_-_47012324
|
0.629
|
|
KIAA0226L
|
KIAA0226-like
|
|
chr12_+_121132677
|
0.621
|
|
|
|
|
chr1_+_207262583
|
0.617
|
NM_000716
NM_001017364
NM_001017367
|
C4BPB
|
complement component 4 binding protein, beta
|
|
chr16_-_29910340
|
0.607
|
NM_001114099
NM_001114100
NM_001243332
NM_001243333
NM_012410
NM_201575
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2
|
|
chr14_-_106209380
|
0.606
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
chr18_+_29171729
|
0.604
|
NM_000371
|
TTR
|
transthyretin
|
|
chr14_+_65878579
|
0.597
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
|
chr16_+_56995761
|
0.592
|
NM_000078
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
chr19_-_36304200
|
0.588
|
NM_021232
|
PRODH2
|
proline dehydrogenase (oxidase) 2
|
|
chr1_-_160549226
|
0.585
|
|
CD84
|
CD84 molecule
|
|
chr19_+_35820069
|
0.572
|
NM_001185099
NM_001185100
NM_001185101
NM_001771
|
CD22
|
CD22 molecule
|
|
chr9_+_35829375
|
0.564
|
NM_001042590
|
TMEM8B
|
transmembrane protein 8B
|
|
chr7_+_94297448
|
0.550
|
|
PEG10
|
paternally expressed 10
|
|
chr19_+_17186569
|
0.539
|
NM_001130065
NM_004145
|
MYO9B
|
myosin IXB
|
|
chr12_+_27485767
|
0.535
|
NM_001248002
NM_001248003
NM_001248004
NM_001248005
NM_020183
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2
|
|
chr11_-_89650877
|
0.530
|
NM_001206627
|
LOC399939
|
ring finger protein 18-like
|
|
chr3_+_50304989
|
0.530
|
NM_001005914
NM_004636
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
chr9_-_123688352
|
0.527
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
chr14_-_107113943
|
0.522
|
|
IGHA1
IGHG1
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
chr12_+_54891491
|
0.521
|
NM_005337
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
chr1_-_205601999
|
0.504
|
NM_001973
NM_021795
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
chr14_-_24423329
|
0.501
|
|
C14orf167
|
chromosome 14 open reading frame 167
|
|
chr3_-_114790221
|
0.498
|
NM_001164343
|
ZBTB20
|
zinc finger and BTB domain containing 20
|
|
chr5_-_138725544
|
0.486
|
NM_016459
|
MZB1
|
marginal zone B and B1 cell-specific protein
|
|
chr8_+_11351509
|
0.485
|
NM_001715
|
BLK
|
B lymphoid tyrosine kinase
|
|
chr2_-_42588300
|
0.481
|
NM_004718
|
COX7A2L
|
cytochrome c oxidase subunit VIIa polypeptide 2 like
|
|
chr17_-_10372875
|
0.476
|
NM_017533
|
MYH4
|
myosin, heavy chain 4, skeletal muscle
|
|
chr15_-_45670624
|
0.467
|
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
|
|
chr1_+_13736906
|
0.465
|
NM_001099852
|
PRAMEF20
|
PRAME family member 20
|
|
chr9_+_35829208
|
0.463
|
NM_016446
NM_001042589
|
TMEM8B
|
transmembrane protein 8B
|
|
chr5_-_171881421
|
0.459
|
NM_001017995
|
SH3PXD2B
|
SH3 and PX domains 2B
|
|
chr14_-_24777160
|
0.457
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
chr1_+_13516065
|
0.454
|
NM_001099852
|
PRAMEF20
|
PRAME family member 20
|
|
chr8_-_102803196
|
0.448
|
|
NCALD
|
neurocalcin delta
|
|
chr12_-_9913415
|
0.441
|
NM_001781
|
CD69
|
CD69 molecule
|
|
chr1_-_156399183
|
0.441
|
NM_006365
|
C1orf61
|
chromosome 1 open reading frame 61
|
|
chr11_+_89659929
|
0.438
|
NM_001206627
|
LOC399939
|
ring finger protein 18-like
|
|
chr14_-_106494166
|
0.436
|
|
IGHV4-31
IGHA1
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy constant alpha 1
|
|
chr19_-_8642337
|
0.435
|
|
MYO1F
|
myosin IF
|
|
chr10_+_131265500
|
0.433
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
chr10_+_131265453
|
0.433
|
NM_002412
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
chr13_-_46756295
|
0.430
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
chr19_-_8642297
|
0.429
|
|
MYO1F
|
myosin IF
|
|
chr1_+_36772696
|
0.418
|
NM_024676
|
SH3D21
|
SH3 domain containing 21
|
|
chr19_-_8642309
|
0.417
|
NM_012335
|
MYO1F
|
myosin IF
|
|
chr10_+_71812356
|
0.412
|
NM_018649
|
H2AFY2
|
H2A histone family, member Y2
|
|
chr11_-_116708334
|
0.404
|
NM_000039
|
APOA1
|
apolipoprotein A-I
|
|
chr22_+_23063107
|
0.398
|
|
IGLJ3
|
immunoglobulin lambda joining 3
|
|
chr21_+_34602205
|
0.393
|
NM_000874
NM_207584
NM_207585
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
chr2_-_89513056
|
0.392
|
|
IGKC
|
immunoglobulin kappa constant
|
|
chr13_-_46756291
|
0.388
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
chr17_+_72462780
|
0.387
|
|
CD300A
|
CD300a molecule
|
|
chr6_-_41715078
|
0.386
|
NM_001166424
NM_002630
|
PGC
|
progastricsin (pepsinogen C)
|
|
chr9_+_71819926
|
0.380
|
NM_001170415
NM_001170416
|
TJP2
|
tight junction protein 2 (zona occludens 2)
|
|
chr13_+_113741668
|
0.379
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr13_-_46756326
|
0.379
|
NM_002298
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
chr22_-_36556781
|
0.373
|
NM_145640
|
APOL3
|
apolipoprotein L, 3
|
|
chr13_+_113812967
|
0.368
|
NM_003891
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
chr6_-_55740358
|
0.364
|
NM_021073
|
BMP5
|
bone morphogenetic protein 5
|
|
chr5_+_59784004
|
0.362
|
|
PART1
|
prostate androgen-regulated transcript 1 (non-protein coding)
|
|
chr13_-_41593405
|
0.358
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
chr3_-_119278402
|
0.358
|
NM_005191
|
CD80
|
CD80 molecule
|
|
chr17_+_75315632
|
0.354
|
|
SEPT9
|
septin 9
|
|
chr16_+_16326478
|
0.352
|
|
NOMO2
|
NODAL modulator 2
|
|
chr3_-_196159304
|
0.351
|
NM_015562
|
UBXN7
|
UBX domain protein 7
|
|
chr17_+_37894212
|
0.350
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr19_+_56158953
|
0.347
|
NM_013301
|
CCDC106
|
coiled-coil domain containing 106
|
|
chr17_+_16318848
|
0.345
|
NM_016113
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
chr17_+_18380097
|
0.343
|
NM_001040078
|
LGALS9B
LGALS9C
|
lectin, galactoside-binding, soluble, 9B
lectin, galactoside-binding, soluble, 9C
|
|
chr7_-_87230170
|
0.343
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
chr17_+_1646129
|
0.339
|
NM_000934
NM_001165921
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
chr17_+_75315590
|
0.336
|
NM_006640
|
SEPT9
|
septin 9
|
|
chr4_+_69962191
|
0.336
|
NM_001074
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
chr7_-_140714730
|
0.328
|
|
MRPS33
|
mitochondrial ribosomal protein S33
|
|
chr3_-_20227618
|
0.325
|
NM_001012409
NM_001012410
NM_001012411
NM_001012412
NM_001012413
NM_138484
NM_001199251
NM_001199252
NM_001199253
NM_001199254
NM_001199255
NM_001199256
NM_001199257
|
SGOL1
|
shugoshin-like 1 (S. pombe)
|
|
chr11_-_63330854
|
0.324
|
NM_017878
|
HRASLS2
|
HRAS-like suppressor 2
|
|
chr5_+_159626047
|
0.324
|
NM_001040442
|
FABP6
|
fatty acid binding protein 6, ileal
|
|
chr1_-_234614848
|
0.323
|
NM_005646
|
TARBP1
|
TAR (HIV-1) RNA binding protein 1
|
|
chr1_-_160832466
|
0.323
|
NM_001166663
NM_001166664
NM_016382
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
chr19_-_54850385
|
0.321
|
NM_012276
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
|
|
chr6_-_55740387
|
0.319
|
|
BMP5
|
bone morphogenetic protein 5
|
|
chr1_+_181003066
|
0.318
|
|
MR1
|
major histocompatibility complex, class I-related
|
|
chr7_+_1127722
|
0.317
|
NM_001098201
|
GPER
|
G protein-coupled estrogen receptor 1
|
|
chr2_+_169312793
|
0.317
|
NM_203463
|
CERS6
|
ceramide synthase 6
|
|
chr11_+_71927818
|
0.317
|
NM_000803
NM_001113534
NM_001113535
NM_001113536
|
FOLR2
|
folate receptor 2 (fetal)
|
|
chr17_+_37894161
|
0.314
|
NM_005310
|
GRB7
|
growth factor receptor-bound protein 7
|
|
chr13_-_99910548
|
0.313
|
NM_001098200
NM_005292
|
GPR18
|
G protein-coupled receptor 18
|
|
chr7_+_134832765
|
0.310
|
NM_018295
|
TMEM140
|
transmembrane protein 140
|
|
chr1_-_93342706
|
0.308
|
NM_001252271
|
FAM69A
|
family with sequence similarity 69, member A
|
|
chr14_-_107170076
|
0.307
|
|
IGHV1-69
IGHG1
|
immunoglobulin heavy variable 1-69
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
chr19_-_51875790
|
0.306
|
NM_005601
|
NKG7
|
natural killer cell group 7 sequence
|
|
chr2_+_97202463
|
0.306
|
NM_212481
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like)
|
|
chr14_-_106725620
|
0.303
|
|
IGHV4-31
IGHV3-23
IGHA1
IGHG1
IGHM
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy variable 3-23
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant mu
|
|
chr16_-_20587625
|
0.302
|
NM_001105069
NM_182617
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B
|
|
chr6_-_43337125
|
0.295
|
NM_014345
|
ZNF318
|
zinc finger protein 318
|
|
chrX_-_131351917
|
0.294
|
NM_021183
|
RAP2C
|
RAP2C, member of RAS oncogene family
|
